Model-Based Drug Development: A Rational Approach to Efficiently Accelerate Drug Development-Reference-Cited by-同舟云学术

Model-Based Drug Development: A Rational Approach to Efficiently Accelerate Drug Development

Published:2013-03-14 Issue:6 Volume:93 Page:502-514
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:
Short-container-title:Clin Pharmacol Ther

Author:

Milligan P A,Brown M J,Marchant B,Martin S W,van der Graaf P H,Benson N,Nucci G,Nichols D J,Boyd R A,Mandema J W,Krishnaswami S,Zwillich S,Gruben D,Anziano R J,Stock T C,Lalonde R L

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Reference66 articles.

1. Model-based Drug Development

2. CPT: Pharmacometrics and Systems Pharmacology

3. Learning versus confirming in clinical drug development*

4. Prevalence and genesis of endometriosis

5. Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: long-term follow-up*1

Cited by 203 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Method “Monte Carlo” in healthcare;World Journal of Methodology;2024-09-20

2. A fully automatic tool for development of population pharmacokinetic models;CPT: Pharmacometrics & Systems Pharmacology;2024-08-27

3. Simulation‐based evaluation of the Pharmpy Automatic Model Development tool for population pharmacokinetic modeling in early clinical drug development;CPT: Pharmacometrics & Systems Pharmacology;2024-08-18

4. Driving Efficiency: Leveraging Model‐Informed Approaches in 505(b)(2) Regulatory Actions;The Journal of Clinical Pharmacology;2024-08-09

5. From Plan to Pivot: How Model‐Informed Drug Development Shaped the Dose Strategy of the Zibotentan/Dapagliflozin ZENITH Trials;Clinical Pharmacology & Therapeutics;2024-07-03